Nasdaq IPOs

Warner Music Group, a leading music publisher and record label, announced terms for its IPO on Tuesday. In its latest filing, the company added BofA Securities, Citi, and J.P. Morgan as joint bookrunners, as well as 22 co-managers. The New York, NY-based company plans to raise $1

Royalty Pharma, which buys royalty interests in marketed and late-stage biopharmas, filed last Friday with the SEC to raise up to $100 million in an initial public offering. However, this is likely a placeholder for a deal we estimate could raise up to $2 billion. The company's p

Royalty Pharma, which buys royalty interests in marketed and late-stage biopharmas, filed last Friday with the SEC to raise up to $100 million in an initial public offering. The company's portfolio consists of royalties on more than 45 marketed therapies and four development-stag

Vaxcyte, a preclinical biotech developing pneumococcal vaccines, filed last Friday with the SEC to raise up to $100 million in an initial public offering. The company's pipeline contains pneumococcal conjugate vaccine (PCV) candidates that it believes are the most broad

Avidity Biosciences, a preclinical biotech developing antibody therapies for muscle disorders, filed last Friday with the SEC to raise up to $100 million in an initial public offering. The company's pipeline contains lead candidate AOC 1001, which is designed to tr

Generation Bio, a preclinical biotech developing gene therapies for rare diseases, filed last Friday with the SEC to raise up to $125 million in an initial public offering. The company's pipeline includes eight programs for rare and prevalent diseases of the liver and r

There are no IPOs scheduled for the 4-day holiday week ahead, but we expect filings to pick up ahead of a semi-active summer. The IPO index touched another all-time high this past week, and the pipeline has a number of potential launches as the IPO market’s spring freeze c

An insurance platform and a medical device company went public this past week, both of which upsized their deals and priced above the range. Two SPACs also went public. The IPO market is continuing to open up, and an uptick in filings is setting the stage for a potentially busy J

Burning Rock Biotech, which provides DNA sequencing-based cancer therapy selection tests in China, filed on Friday with the SEC to raise up to $100 million in an initial public offering. The company provides next-generation sequencing-based cancer therapy selection tests that are

Inari Medical, which makes minimally invasive medical devices for venous diseases, raised $156 million by offering 8.2 million shares at $19, above the upwardly revised range of $17 to $18. The company had originally filed to offer 7.3 million shares at a range of $14 to $16. Ins

Hudson Executive Investment, a blank company formed by Hudson Executive Capital targeting fintech or healthcare, filed on Thursday with the SEC to raise up to $300 million in an initial public offering. The company plans to raise an additional $50 million through a forward purcha

The OLB Group, a merchant acquirer with a suite of payment services, lowered the proposed deal size for its upcoming IPO on Thursday. The New York, NY-based company now plans to raise $5 million by offering 0.7 million shares at a price of $7.60. The company had previously filed

Inari Medical, which makes minimally invasive medical devices for venous diseases, raised the proposed range for its upcoming IPO on Thursday. The Irvine, CA-based company now plans to raise $128 million by offering 7.3 million shares at a price range of $17 to $18. The company h

Longview Acquisition, a blank check company formed by executives at healthcare-focused hedge fund Glenview Capital, raised $360 million by offering 36 million shares at $10, the low end of the range of $10 to $10. Longview Acquisition plans to list on the NYSE under the symbol LG

SelectQuote, which distributes Medicare Advantage and other insurance products, raised $570 million by offering 28.5 million shares (37% from selling shareholders) at $20, above the range of $17 to $19. The company had originally planned to sell 25 million shares; all of the adde

B. Riley Principal Merger II, the second blank check company formed by diversified financial services firm B. Riley Financial, raised $175 million by offering 17.5 million units at $10. The company originally planned to offer 20 million units, making B. Riley Principal Merger II

B. Riley Principal Merger II, the second blank check company formed by diversified financial services firm B. Riley Financial, raised $175 million by offering 17.5 million units at $10. The company originally planned to offer 20 million units. Each unit consists of one share

The Nasdaq is reportedly planning to add new listing requirements which will limit IPOs from illiquid micro-cap Chinese companies. According to Reuters, the new rules would require issuers from China and certain other countries to either raise $25 million or float at least 25% of

The Nasdaq is reportedly planning to add new listing requirements which will limit IPOs from illiquid micro-cap Chinese companies. According to Reuters, the new rules would require issuers from China and certain other countries to either raise $25 million or float at least 25% of

The Nasdaq is reportedly planning to add new listing requirements which will limit IPOs from illiquid micro-cap Chinese companies. According to Reuters, the new rules would require issuers from China and certain other countries to either raise $25 million or float at least 25% of